Compounds > bromocriptine
Page last updated: 2024-08-23

bromocriptine and Acromegaly Due To Pituitary Adenoma

bromocriptine has been researched along with Acromegaly Due To Pituitary Adenoma in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19901 (9.09)18.7374
1990's0 (0.00)18.2507
2000's4 (36.36)29.6817
2010's1 (9.09)24.3611
2020's5 (45.45)2.80

Authors

AuthorsStudies
Auriemma, RS; Colao, A; Negri, M; Patalano, R; Pirchio, R; Pivonello, C; Pivonello, R1
Okayama, A; Sato, T; Shimatsu, A; Yamaguchi, H1
Kawakami, K; Matsubayashi, K1
Oearsakul, T; Taweesomboonyat, C1
Chen, Y; Fang, Q; Gao, H; Gui, S; Guo, J; Li, C; Liu, C; Wang, J; Wang, Z; Xie, W; Zhang, Y; Zhao, P; Zhu, H1
Cha, HJ; Kim, JH; Kim, SW; Kim, YH; Lee, JH; Lee, SY; Paek, SH; Shin, CS1
Mezosi, E; Nemes, O1
Ducottet-Valdant, MC; Luton, JP; Meyer, B; Paupe, J; Scheinmann, P; Vialatte, J1
Biermasz, NR; Pereira, AM; Roelfsema, F; Romijn, JA1
Fujita, T; Nishina, Y; Takano, K; Teramoto, A; Yasufuku-Takano, J1
Colao, A; Di Somma, C; Lombardi, G; Pivonello, R; Savastano, S; Tauchmanovà, L1

Reviews

3 review(s) available for bromocriptine and Acromegaly Due To Pituitary Adenoma

ArticleYear
Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms.
    Frontiers in endocrinology, 2021, Volume: 12

    Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Aminoquinolines; beta-Arrestins; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Filamins; Growth Hormone-Secreting Pituitary Adenoma; Humans; Lisuride; MicroRNAs; Pergolide; Pituitary Neoplasms; Prolactinoma; Receptors, Dopamine D2

2021
[Treatment of pituitary adenomas].
    Orvosi hetilap, 2009, Sep-27, Volume: 150, Issue:39

    Topics: Acromegaly; ACTH-Secreting Pituitary Adenoma; Adenoma; Adrenocorticotropic Hormone; Aminoquinolines; Bromocriptine; Cushing Syndrome; Dopamine Agonists; Female; Growth Hormone-Secreting Pituitary Adenoma; Human Growth Hormone; Humans; Hypophysectomy; Incidental Findings; Male; Pituitary Hormones; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma; Radiosurgery; Receptors, Somatotropin; Somatostatin; Thyrotropin

2009
Current pharmacotherapy for acromegaly: a review.
    Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:14

    Topics: Acromegaly; Adenoma; Algorithms; Bromocriptine; Clinical Trials as Topic; Combined Modality Therapy; Costs and Cost Analysis; Delayed-Action Preparations; Dopamine Agonists; Drug Administration Schedule; Female; Growth Hormone-Secreting Pituitary Adenoma; Human Growth Hormone; Humans; Neoadjuvant Therapy; Octreotide; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications; Receptors, Somatotropin; Somatostatin

2005

Other Studies

8 other study(ies) available for bromocriptine and Acromegaly Due To Pituitary Adenoma

ArticleYear
Long-term safety and treatment outcomes of pegvisomant in Japanese patients with acromegaly: results from the post-marketing surveillance.
    Endocrine journal, 2020, Feb-28, Volume: 67, Issue:2

    Topics: Acromegaly; Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Bromocriptine; Cabergoline; Chemical and Drug Induced Liver Injury; Child; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Female; Growth Hormone-Secreting Pituitary Adenoma; Human Growth Hormone; Humans; Hypoglycemia; Insulin-Like Growth Factor I; Japan; Male; Middle Aged; Neurosurgical Procedures; Octreotide; Peptides, Cyclic; Product Surveillance, Postmarketing; Radiotherapy; Receptors, Somatotropin; Somatostatin; Tumor Burden; Young Adult

2020
Prevalence, incidence, comorbidities, and treatment patterns among Japanese patients with acromegaly: a descriptive study using a nationwide claims database.
    Endocrine journal, 2020, Oct-28, Volume: 67, Issue:10

    Topics: Acromegaly; Adenoma; Adult; Aged; Antineoplastic Agents, Hormonal; Bromocriptine; Cabergoline; Comorbidity; Dopamine Agonists; Female; Growth Hormone-Secreting Pituitary Adenoma; Human Growth Hormone; Humans; Hyperlipidemias; Hypertension; Incidence; Japan; Male; Middle Aged; Neurosurgical Procedures; Octreotide; Peptides, Cyclic; Prevalence; Radiosurgery; Radiotherapy, Intensity-Modulated; Retrospective Studies; Somatostatin; Young Adult

2020
Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery.
    World neurosurgery, 2021, Volume: 146

    Topics: Acromegaly; Adult; Antineoplastic Agents, Hormonal; Bromocriptine; Chemotherapy, Adjuvant; Female; Growth Hormone-Secreting Pituitary Adenoma; Hormone Antagonists; Humans; Insulin-Like Growth Factor I; Logistic Models; Male; Microsurgery; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neuroendoscopy; Neurosurgical Procedures; Pituitary Neoplasms; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Reoperation; Retrospective Studies; Sex Factors; Sphenoid Sinus; Treatment Failure; Treatment Outcome; Tumor Burden

2021
Genomic and transcriptomic analysis of pituitary adenomas reveals the impacts of copy number variations on gene expression and clinical prognosis among prolactin-secreting subtype.
    Aging, 2020, 12-19, Volume: 13, Issue:1

    Topics: Adenoma; Adult; Aged; Bromocriptine; Cell Proliferation; DNA Copy Number Variations; Dopamine Agonists; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genomics; Growth Hormone-Secreting Pituitary Adenoma; Humans; Male; Middle Aged; Neoplasm Invasiveness; Oncogene Proteins v-erbB; Organelle Biogenesis; Pituitary Neoplasms; Prognosis; Prolactin; Prolactinoma; Proto-Oncogene Proteins c-myc; Ribosomes; RNA-Seq; Signal Transduction; TOR Serine-Threonine Kinases; Transaminases; Whole Genome Sequencing; Young Adult

2020
The efficacy of medical treatment in patients with acromegaly in clinical practice.
    Endocrine journal, 2018, Jan-30, Volume: 65, Issue:1

    Topics: Acromegaly; Adenoma; Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Cohort Studies; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Female; Follow-Up Studies; Growth Hormone-Secreting Pituitary Adenoma; Hospitals, University; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Neoplasm Grading; Republic of Korea; Retrospective Studies; Somatostatin; Tumor Burden

2018
[Acromegalogigantism].
    Annales de pediatrie, 1977, Volume: 24, Issue:4

    Topics: Acromegaly; Adenoma, Acidophil; Adolescent; Body Height; Bromocriptine; Diagnosis, Differential; Gigantism; Growth Hormone-Secreting Pituitary Adenoma; Hormone Antagonists; Humans; Hypophysectomy; Male; Pituitary Irradiation; Retreatment

1977
Mechanism of D(2) agonist-induced inhibition of GH secretion from human GH-secreting adenoma cells.
    Endocrine journal, 2005, Volume: 52, Issue:6

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenoma; Bromocriptine; Calcium; Calcium Channels; Dopamine Agonists; Dose-Response Relationship, Drug; Growth Hormone-Secreting Pituitary Adenoma; Human Growth Hormone; Humans; Nitrendipine; Pertussis Toxin; Receptors, Dopamine; Sodium Channels; Tumor Cells, Cultured

2005
Growth hormone excess with onset in adolescence: clinical appearance and long-term treatment outcome.
    Clinical endocrinology, 2007, Volume: 66, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Agents, Hormonal; Body Height; Body Mass Index; Bromocriptine; Cabergoline; Combined Modality Therapy; Ergolines; Female; Growth Hormone; Growth Hormone-Secreting Pituitary Adenoma; Headache; Hormone Antagonists; Humans; Insulin Resistance; Insulin-Like Growth Factor I; Male; Menstruation Disturbances; Octreotide; Peptides, Cyclic; Pituitary Neoplasms; Retrospective Studies; Somatostatin; Treatment Outcome

2007